These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1715220)

  • 21. Elucidation of structural requirements on plasminogen activator inhibitor 1 for binding to heparin.
    Ehrlich HJ; Gebbink RK; Keijer J; Pannekoek H
    J Biol Chem; 1992 Jun; 267(16):11606-11. PubMed ID: 1375944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.
    Kirchheimer JC; Binder BR; Remold HG
    J Immunol; 1990 Sep; 145(5):1518-22. PubMed ID: 1696600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin.
    Urano T; Ihara H; Takada Y; Nagai N; Takada A
    Biochim Biophys Acta; 1996 Dec; 1298(2):199-208. PubMed ID: 8980646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational and immunochemical analysis of plasminogen activator inhibitor 1.
    Shubeita HE; Cottey TL; Franke AE; Gerard RD
    J Biol Chem; 1990 Oct; 265(30):18379-85. PubMed ID: 2120233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.
    Theunissen HJ; Dijkema R; Grootenhuis PD; Swinkels JC; de Poorter TL; Carati P; Visser A
    J Biol Chem; 1993 Apr; 268(12):9035-40. PubMed ID: 8473344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H
    Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators.
    Tucker HM; Gerard RD
    Eur J Biochem; 1996 Apr; 237(1):180-7. PubMed ID: 8620872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity.
    Urano T; Ihara H; Suzuki Y; Takada Y; Takada A
    Semin Thromb Hemost; 2000; 26(1):39-42. PubMed ID: 10805280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase.
    Ke SH; Coombs GS; Tachias K; Navre M; Corey DR; Madison EL
    J Biol Chem; 1997 Jun; 272(26):16603-9. PubMed ID: 9195973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
    Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
    Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N; Villannueva GB; Fenton JW
    Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.
    Bruckner A; Filderman AE; Kirchheimer JC; Binder BR; Remold HG
    Cancer Res; 1992 Jun; 52(11):3043-7. PubMed ID: 1375533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
    Kruithof EK; Gudinchet A; Bachmann F
    Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
    Lijnen HR; Uytterhoeven M; Collen D
    Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.
    Salonen EM; Vaheri A; Pöllänen J; Stephens R; Andreasen P; Mayer M; Danø K; Gailit J; Ruoslahti E
    J Biol Chem; 1989 Apr; 264(11):6339-43. PubMed ID: 2467912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
    Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.